Pershing Square Activist Presentation Deck slide image

Pershing Square Activist Presentation Deck

Pricing has Driven Growth Allergan has relied on large price increases to drive revenue growth, both historically and in 2014 7-9% Price Increases in 2014 ■ Acuvail ■ Elestat Lastacraft ■ Betagan ■ Zymaxid 10%+ Price Increases in 2014 ■ Alphagan ■ Combigan Lumigan ■ Restasis ■ Aczone ■ Tazorac ■ Avage ■ Azalex Source: Wolters Kluwer: Med-Span Price Rx and Valeant management estimates. 60 100% + Price Increases in 2014 ■ Pred-G ■ Pred Miled FML Forte Bleph-10
View entire presentation